Brief: Sciclone Pharmaceuticals Says HY Net Profit About Rmb622.7 Mln, Up 4.3%
Aug 20 (Reuters) - SciClone Pharmaceuticals (Holdings) Ltd
6600.HK :
* HY NET PROFIT ABOUT RMB622.7 MILLION, UP 4.3%
* HY REVENUE ABOUT RMB1,331.3 MILLION, UP ABOUT 14.7%
Further company coverage: 6600.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SciClone Pharmaceuticals (Holdings)
See all newsOneRobotics surges on plan to buy more shares
Brief: Onerobotics (Shenzhen) To Procure Affiliate Of Co To Acquire 59.9% Stake Of Nanoleaf Limited, Others
Brief: OneRobotics (Shenzhen) Says Final Offer Price Under Global Offering Is HK$73.80 Per H Share
Brief: Sciclone Pharmaceuticals (Holdings) Announces Proposal For Privatisation Of Co By Silver Pegasus Investment
Brief: SciClone Pharmaceuticals Says Trading In Shares Halted